𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection

✍ Scribed by Hata, Akito; Katakami, Nobuyuki; Yoshioka, Hiroshige; Fujita, Shiro; Kunimasa, Kei; Nanjo, Shigeki; Otsuka, Kyoko; Kaji, Reiko; Tomii, Keisuke; Iwasaku, Masahiro; Nishiyama, Akihiro; Hayashi, Hidetoshi; Morita, Satoshi; Ishida, Tadashi


Book ID
119320585
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
242 KB
Volume
74
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES